Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine plus speech-language therapy for post-stroke non-fluent aphasia
ChiCTR2400085793Phase 4Completed
- Sponsor
- China Rehabilitation Research Center
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of memantine in aphasia (2 arms), sponsored by China Rehabilitation Research Center. Primary endpoint: Western Aphasia Battery Aphasia Quotient (WAB-AQ) at week 16. Started Jun 2024; status: completed.
02
Drugs
memantine
03
Conditions
aphasia
Beyond the preview
Go deeper on ChiCTR2400085793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085793.